Tuazon, Noriel T.

HRN: 21-78-03  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/18/2022
CEFUROXIME 1.5GM (VIAL)
08/18/2022
08/25/2022
IV
1.5g
Q8
For Prophylaxis Surgical
Waiting Final Action 
09/18/2022
CEFUROXIME 1.5GM (VIAL)
09/19/2022
09/19/2022
IV
1.5g
SD
Surgical Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: